Your session is about to expire
← Back to Search
Hyperpolarized [13C]Pyruvate for Brain Metabolism (HP Brain Trial)
Phase < 1
Waitlist Available
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 through 60 years of age.
Healthy, with no neurological abnormalities.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measurements made during study scan
Awards & highlights
HP Brain Trial Summary
This trial will develop a new MRI technique to better understand how the brain uses energy, which could helpdiagnose and treat neurological disorders.
HP Brain Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHP Brain Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measurements made during study scan
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measurements made during study scan
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Development of 13C ratio maps in the brain of healthy participants
HP Brain Trial Design
1Treatment groups
Experimental Treatment
Group I: Hyperpolarized [13C]pyruvateExperimental Treatment1 Intervention
Hyperpolarized stable isotope injection ([13C]pyruvate) during magnetic resonance spectroscopic imaging
Find a Location
Who is running the clinical trial?
University of Texas Southwestern Medical CenterLead Sponsor
1,040 Previous Clinical Trials
1,048,078 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger